Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

A label free colorimetric assay for the detection of active botulinum neurotoxin type A by SNAP-25 conjugated colloidal gold.

Halliwell J, Gwenin C.

Toxins (Basel). 2013 Aug 6;5(8):1381-91. doi: 10.3390/toxins5081381.

PMID:
23925142
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

A substrate sensor chip to assay the enzymatic activity of Botulinum neurotoxin A.

Lévêque C, Ferracci G, Maulet Y, Grand-Masson C, Blanchard MP, Seagar M, El Far O.

Biosens Bioelectron. 2013 Nov 15;49:276-81. doi: 10.1016/j.bios.2013.05.032. Epub 2013 May 29.

PMID:
23787358
[PubMed - indexed for MEDLINE]
3.

Comparison of the catalytic properties of the botulinum neurotoxin subtypes A1 and A5.

Wang D, Krilich J, Pellett S, Baudys J, Tepp WH, Barr JR, Johnson EA, Kalb SR.

Biochim Biophys Acta. 2013 Dec;1834(12):2722-8. doi: 10.1016/j.bbapap.2013.09.007. Epub 2013 Oct 2.

PMID:
24096023
[PubMed - indexed for MEDLINE]
Free Article
4.

Recombinant SNAP-25 is an effective substrate for Clostridium botulinum type A toxin endopeptidase activity in vitro.

Ekong TA, Feavers IM, Sesardic D.

Microbiology. 1997 Oct;143 ( Pt 10):3337-47.

PMID:
9353935
[PubMed - indexed for MEDLINE]
Free Article
5.

Enhancement of the endopeptidase activity of botulinum neurotoxin by its associated proteins and dithiothreitol.

Cai S, Sarkar HK, Singh BR.

Biochemistry. 1999 May 25;38(21):6903-10.

PMID:
10346912
[PubMed - indexed for MEDLINE]
6.

Development of an in vitro bioassay for Clostridium botulinum type B neurotoxin in foods that is more sensitive than the mouse bioassay.

Wictome M, Newton K, Jameson K, Hallis B, Dunnigan P, Mackay E, Clarke S, Taylor R, Gaze J, Foster K, Shone C.

Appl Environ Microbiol. 1999 Sep;65(9):3787-92.

PMID:
10473376
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

The C terminus of the catalytic domain of type A botulinum neurotoxin may facilitate product release from the active site.

Mizanur RM, Frasca V, Swaminathan S, Bavari S, Webb R, Smith LA, Ahmed SA.

J Biol Chem. 2013 Aug 16;288(33):24223-33. doi: 10.1074/jbc.M113.451286. Epub 2013 Jun 18.

PMID:
23779108
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Universal and specific quantitative detection of botulinum neurotoxin genes.

Hill BJ, Skerry JC, Smith TJ, Arnon SS, Douek DC.

BMC Microbiol. 2010 Oct 20;10:267. doi: 10.1186/1471-2180-10-267.

PMID:
20961439
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Development of an in vitro activity assay as an alternative to the mouse bioassay for Clostridium botulinum neurotoxin type A.

Rasooly R, Do PM.

Appl Environ Microbiol. 2008 Jul;74(14):4309-13. doi: 10.1128/AEM.00617-08. Epub 2008 May 30.

PMID:
18515481
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

A sensitive and useful radioimmunoassay for neurotoxin and its haemagglutinin complex from Clostridium botulinum.

Ashton AC, Crowther JS, Dolly JO.

Toxicon. 1985;23(2):235-46.

PMID:
3895579
[PubMed - indexed for MEDLINE]
11.

Development of novel assays for botulinum type A and B neurotoxins based on their endopeptidase activities.

Hallis B, James BA, Shone CC.

J Clin Microbiol. 1996 Aug;34(8):1934-8.

PMID:
8818885
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Botulinum neurotoxin detection and differentiation by mass spectrometry.

Barr JR, Moura H, Boyer AE, Woolfitt AR, Kalb SR, Pavlopoulos A, McWilliams LG, Schmidt JG, Martinez RA, Ashley DL.

Emerg Infect Dis. 2005 Oct;11(10):1578-83.

PMID:
16318699
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Light chain separated from the rest of the type a botulinum neurotoxin molecule is the most catalytically active form.

Gul N, Smith LA, Ahmed SA.

PLoS One. 2010 Sep 22;5(9):e12872. doi: 10.1371/journal.pone.0012872.

PMID:
20877571
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Development of an immunodetection test for a botulinum-like neurotoxin produced by Clostridium sp. RKD.

Dixit A, Alam SI, Dhaked RK, Singh L.

Indian J Med Res. 2006 Sep;124(3):355-62.

PMID:
17085839
[PubMed - indexed for MEDLINE]
15.

Clostridium botulinum type D neurotoxin: purification and detection.

De Jongh KS, Schwartzkoff CL, Howden ME.

Toxicon. 1989;27(2):221-8.

PMID:
2655181
[PubMed - indexed for MEDLINE]
16.

Detection of botulinum neurotoxin serotypes A and B using a chemiluminescent versus electrochemiluminescent immunoassay in food and serum.

Cheng LW, Stanker LH.

J Agric Food Chem. 2013 Jan 23;61(3):755-60. doi: 10.1021/jf3041963. Epub 2013 Jan 10.

PMID:
23265581
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Bioluminescence assay for the highly sensitive detection of botulinum neurotoxin A activity.

Stevens GB, Silver DA, Zgaga-Griesz A, Bessler WG, Vashist SK, Patel P, Achazi K, Strotmeier J, Worbs S, Dorner MB, Dorner BG, Pauly D, Rummel A, Urban GA, Krueger M.

Analyst. 2013 Oct 21;138(20):6154-62. doi: 10.1039/c3an00525a.

PMID:
23971072
[PubMed - indexed for MEDLINE]
18.

Development of sensitive colorimetric capture elisas for Clostridium botulinum neurotoxin serotypes A and B.

Szílagyi M, Rivera VR, Neal D, Merrill GA, Poli MA.

Toxicon. 2000 Mar;38(3):381-9.

PMID:
10669027
[PubMed - indexed for MEDLINE]
19.

A quadruplex real-time PCR assay for rapid detection and differentiation of the Clostridium botulinum toxin genes A, B, E and F.

Satterfield BA, Stewart AF, Lew CS, Pickett DO, Cohen MN, Moore EA, Luedtke PF, O'Neill KL, Robison RA.

J Med Microbiol. 2010 Jan;59(Pt 1):55-64. doi: 10.1099/jmm.0.012567-0. Epub .

PMID:
19779029
[PubMed - indexed for MEDLINE]
Free Article
20.

[Development and optimization of immunoassays for the detection of botulinum toxins].

Titov AA, Shilenko IV, Morozov AA, Iarkov SP, Zlobin VN.

Prikl Biokhim Mikrobiol. 2012 Mar-Apr;48(2):249-56. Russian.

PMID:
22586920
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk